Grant: Alliance Grants
Institut national de la recherche scientifique
$50,000.00
Photoelectrochemical biosensing for COVID-19: virus and antibodies_x000d_ _x000d_
EF 2020-21
Résumé
This project aims to develop an efficient antibody sensor, as preventive measure for detection of infections caused by COVID19. It addresses a problem of crucial importance for Canada and for Solstar Pharma, a Canadian company which focuses on research & development of antimicrobial, anti-viral and anti-cancer agents for the treatment of life-threatening diseases.
Our objective is to develop a Photoelectrochemical (PEC) biosensor based on photoactive nanoparticles such as Quantum Dots (QDs) for the detection of COVID19 and related antibodies. Highly efficient QDs based on engineered core/multi-shelled structures will be developed and their interaction with the molecular recognition element (MRE) layer it will be investigated. An in-depth study of the QDs-MRE ligands structure vs. properties will be pursued, to improve efficiency (by reducing recombination events) and the sensitivity of the biosensor by exploiting the synergistic effect of QD photoactive materials and MRE surface functionalization. To develop a consistent structure-property picture of virus and antibody detection, we will study the relationship between QD-ligands structures and detection performance, to realize a new PEC biosensor that can used in different conditions, under specific types of lighting (sunlight or low-power diodes).
This research will be conducted in close collaboration between the Solstar Pharma R&D team and Prof. Rosei who will be assisted by one postdoctoral fellow during the whole duration of the project. The expected impact and outcome will be the realization of a PEC biosensor for detecting COVID antibodies. In particular, the final miniaturized, low-cost and highly sensitive biosensor will have a major positive impact on Canada's health sector and economy.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
555354-2020
Name nom
Rosei, Federico
Department département
Énergie Matériaux Télécommunications, Centre - Montréal
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Photoelectrochemical biosensing for COVID-19: virus and antibodies_x000d_
_x000d_
Keyword
NSERC
Application summary
This project aims to develop an efficient antibody sensor, as preventive measure for detection of infections caused by COVID19. It addresses a problem of crucial importance for Canada and for Solstar Pharma, a Canadian company which focuses on research & development of antimicrobial, anti-viral and anti-cancer agents for the treatment of life-threatening diseases.
Our objective is to develop a Photoelectrochemical (PEC) biosensor based on photoactive nanoparticles such as Quantum Dots (QDs) for the detection of COVID19 and related antibodies. Highly efficient QDs based on engineered core/multi-shelled structures will be developed and their interaction with the molecular recognition element (MRE) layer it will be investigated. An in-depth study of the QDs-MRE ligands structure vs. properties will be pursued, to improve efficiency (by reducing recombination events) and the sensitivity of the biosensor by exploiting the synergistic effect of QD photoactive materials and MRE surface functionalization. To develop a consistent structure-property picture of virus and antibody detection, we will study the relationship between QD-ligands structures and detection performance, to realize a new PEC biosensor that can used in different conditions, under specific types of lighting (sunlight or low-power diodes).
This research will be conducted in close collaboration between the Solstar Pharma R&D team and Prof. Rosei who will be assisted by one postdoctoral fellow during the whole duration of the project. The expected impact and outcome will be the realization of a PEC biosensor for detecting COVID antibodies. In particular, the final miniaturized, low-cost and highly sensitive biosensor will have a major positive impact on Canada's health sector and economy.